Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trial
The STELLAR trial was registered at ClinicalTrials.gov (identifier: NCT02533271); however, this post hoc analysis was retrospectively conducted.
Authors
- yexiong Li
- Haoyue Li (ORCID: https://orcid.org/0000-0001-8854-0500)
- Huiying Ma
- Jiacheng Shuai
- Yongwen Song
- Ningning Lu
- Shulian Wang
- Jinming Shi
- Tongzhen Xu
- Guanghui Cheng
- Shixin Liu
- Aiping Zhou
- Yuanhong Gao
- Wenjue Zhang
- Ke Liu
- Yuan Tang
- Lichun Wei
- Yongjing Yang
- Yongheng Li
- Wenwen Zhang
- Jing Jin
- Haitao Zhou
- Ning Li
- Xin Wang
- Yong Cai
- Jun Wang
- Weiwei Xiao
- WenGuang Luo
- Hui Fang
- Yueping Liu
- Liming Jiang
Institutions
- Hebei Medical University (CN)
- University of Science and Technology of China (CN)
- Sun Yat-sen University (CN)
- Jilin University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- National Cancer Center (US)
- West China Hospital of Sichuan University (CN)
- Peking University Cancer Hospital (CN)
- Shanxi Provincial Cancer Hospital (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Hunan Cancer Hospital (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
- Sun Yat-sen University Cancer Center (CN)
- Xijing Hospital (CN)
- Union Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1186/s12916-026-04731-0
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00